G
Guy Decaux
Researcher at Erasmus University Rotterdam
Publications - 170
Citations - 7513
Guy Decaux is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Hyponatremia & Antidiuretic. The author has an hindex of 44, co-authored 164 publications receiving 6839 citations. Previous affiliations of Guy Decaux include Université libre de Bruxelles & Free University of Brussels.
Papers
More filters
Journal ArticleDOI
Clinical practice guideline on diagnosis and treatment of hyponatraemia
Goce Spasovski,Raymond Vanholder,Bruno Allolio,Djillali Annane,Steve S. Ball,Daniel G. Bichet,Guy Decaux,Wiebke W. Fenske,Ewout J. Hoorn,Carole Ichai,Michael Joannidis,Alain Soupart,Robert Zietse,Maria M. Haller,Sabine S. Van Der Veer,Wim Van Biesen,E Nagler +16 more
TL;DR: The Clinical Practice Guideline on the diagnostic approach and treatment of hyponatraemia is developed as a joint venture of three societies representing specialists with a natural interest in hyponatonemia to obtain a common and holistic view.
Journal ArticleDOI
Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits.
TL;DR: Mild chronic hyponatremia induces a high incidence of falls possibly as the result of marked gait and attention impairments, and treating these patients might prevent a considerable number of hospitalizations.
Journal ArticleDOI
Non-peptide arginine-vasopressin antagonists: the vaptans
TL;DR: The vaptans are orally and intravenously active non-peptide vasopressin receptor antagonists that are in development and have shown initial positive results in the treatment of Raynaud's disease, dysmenorrhoea, and tocolysis.
Journal ArticleDOI
Mild hyponatremia and risk of fracture in the ambulatory elderly.
TL;DR: Mild asymptomatic hypon atremia is associated with bone fracture in ambulatory elderly and avoiding iatrogenic hyponatremia or treating hyponAtremia may decrease the number of bone fractures in this population.
Journal ArticleDOI
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: A randomized double-blind multicenter trial
Alexander L. Gerbes,Veit Gülberg,Pere Ginès,Guy Decaux,Peter Gross,Hassan Gandjini,Jacques Djian +6 more
TL;DR: An orally active vasopressin receptor antagonist can correct hyponatremia in patients with Cirrhosis and ascites and represents a novel therapy of water retention in cirrhosis.